Mashup Score:90
PubMedTwitter Feed: SABOURETCardiologist
This meta-analysis report that GLP1-RA and SGLT2i reduced with a similar efficacy not only MACE as MI, but also cardiovascular mortality and all-cause mortality...
-
RT @SABOURETCardio: Comparing benefits from #SGLT2i and #GLP1RA #MA https://t.co/oalIaXGYxi - view on twitter
Mashup Score:47
ScienceDirectLipoprotein(a), the rediscovered risk factor, or how to get “back to the future” - 1 week
Mashup Score:47
Journals & BooksSearchRegisterSign inView PDFView Open ManuscriptArchives of Cardiovascular DiseasesVolume 113, Issue 3, March 2020, Pages 147-151Author links open overlay panel, , https://doi.org/10.1016/j.acvd.2020.03.008Get rights and...
-
Link with free access: https://t.co/cJlQw9DwC6 #Lpa awareness #LLT #lipids - view on twitter
AbstractAims . Clinical trials have demonstrated that a reduction in low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular (CV) events. This has,...
-
« The earlier, the deeper, the longer, the better » #LDL and statin intensity in #ACS and #MACE a Swedish nationwide cohort study | European Heart Journal | Oxford Academic https://t.co/8gwuyeL4eb - view on twitter
Mashup Score:22
OUP AcademicInitial statin dose after myocardial infarction and long-term cardiovascular outcomes - 1 week
Mashup Score:22
AbstractAims. Effective statin therapy is a cornerstone of secondary prevention after myocardial infarction (MI). Real-life statin dosing is nevertheless...
-
I already made the promotion of this article but I tweet again as we have 3 recent large databases advocating an early and intensive #LLT strategy. Initial statin dose after #ACS and long term #Prognosis #lipids https://t.co/J7WydB0QUi - view on twitter
Mashup Score:20
European Journal of Internal MedicineSince more than two decades, dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is considered the gold standard for patients with...
-
De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy? - European Journal of Internal Medicine https://t.co/S9rtR4ax3J - view on twitter
Mashup Score:15
European Journal of Internal MedicineSince more than two decades, dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is considered the gold standard for patients with...
-
#DAPT #DeEscalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy? https://t.co/rwnRPrVRYl - view on twitter
Mashup Score:14
HeartPrevention and treatment of premature ischaemic heart disease with European Society of Cardiology Guidelines - 15 hours
Mashup Score:14
Objective To determine if the changes in the European Society Cardiology/European Atherosclerotic Society (ESC/EAS) guidelines improved the identification for primary prevention therapy in young...
-
#LLT #lipids. Last #ESC #Guidelines improve the evaluation of #CVR in the young, but after #ACS, many patients don't reach targets #IRL https://t.co/aV9HwmKzs8 - view on twitter
Italian return to play protocol after COVID-19 in young competitive and professional athletes: diagnostic yield and cost-benefit...
-
RT @SABOURETCardio: Return to play after #Covid19 https://t.co/RDrVzyJdg5 - view on twitter
More coverage:
#covid19
Mashup Score:12
OUP AcademicLDL lowering effect of PCSK9 inhibition is reduced in women - 1 week
Mashup Score:12
AbstractAims. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of plasma low-density lipoprotein cholesterol (LDL-C) concentration,...
-
#LDL lowering effect of #PCSK9i inhibition is reduced in #women. Interesting data to compare with #RCT https://t.co/YDBTzZ2N5H - view on twitter
Major international practice guidelines recommend the use of a combination of 4 medication classes in the treatment of patients with heart failure with reduced...
RT @SABOURETCardio: Optimisation of treatments for #HFrEF in routine practice. https://t.co/d2t7TqCsYK #HF - view on twitter